About Nirmidas
Nirmidas is a company based in Palo Alto (United States) founded in 2013. Nirmidas has raised $2 million across 3 funding rounds from investors including HHS and StartX. The company has 5 employees as of December 31, 2022. Nirmidas offers products and services including Biotech Diagnostics & Imaging Products. Nirmidas operates in a competitive market with competitors including Oxford Instruments, Tomocube, VisEn Medical, Lyncee Tec and Bioaxial, among others.
- Headquarter Palo Alto, United States
- Employees 5 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nirmidas Biotech, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2 M (USD)
in 3 rounds
-
Latest Funding Round
$421.71 K (USD), Grant
Apr 01, 2017
-
Investors
HHS
& 1 more
-
Employee Count
5
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nirmidas
Nirmidas offers a comprehensive portfolio of products and services, including Biotech Diagnostics & Imaging Products.
Tools for life science research and clinical diagnostics via NIR technology.
People of Nirmidas
Unlock access to complete
Unlock access to complete
Funding Insights of Nirmidas
Nirmidas has successfully raised a total of $2M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $421.71 thousand completed in April 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Nirmidas
Nirmidas has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS and StartX.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Startups are accelerated by Stanford-backed program in Palo Alto.
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for Nirmidas
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nirmidas
Investment portfolio details for Nirmidas
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nirmidas
Detailed financials for Nirmidas
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nirmidas Comparisons
Peer comparison for Nirmidas
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nirmidas
Nirmidas operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Oxford Instruments, Tomocube, VisEn Medical, Lyncee Tec and Bioaxial, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Technology tools and systems for molecular scale are developed.
|
|
| Locked | Locked | Locked |
Holographic microtomography is utilized for live cell imaging in microscopy.
|
|
| Locked | Locked | Locked |
Fluorescence in-vivo imaging technology platforms are developed and commercialized.
|
|
| Locked | Locked | Locked |
Digital holographic microscopy solutions for profilometry and imaging are provided.
|
|
| Locked | Locked | Locked |
Developing super-resolution imaging solutions for medical applications
|
|
| Locked | Locked | Locked |
X-ray imaging solutions
|
Detailed competitors of Nirmidas
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nirmidas
Complete news archive for Nirmidas
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nirmidas
Nirmidas was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Nirmidas is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
Nirmidas is a funded company, having raised a total of $2M across 3 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Nirmidas is 5.
Nirmidas develops and manufactures technologies in biological testing, assays, and imaging, based on a red to near-infrared fluorescence enhancing detection platform. They aim to develop personal and portable diagnostic systems for early disease diagnosis and prognosis monitoring, as well as for population-based screening applications. The product portfolio includes the following: MidaScan-IR is a dual channel (700 nm and 800 nm) near-infrared (NIR) confocal microscope scanner for imaging tissues, cells, and microarrays on standard glass or plasmonic slides; pGOLD platform is a nano-engineered, near-infrared fluorescence enhancing imaging and detection platform; pGold Beads and pMag Beads are used for bead assays with redNIR dyes and magnetic and fluorescence enabled Separation and enrichment of proteins, antibodies, and nucleic acids respectively.
Nirmidas's top competitors include Oxford Instruments, Tomocube and CrestOptics.
Nirmidas offers Biotech Diagnostics & Imaging Products.